Cancer metabolism is a critical area of research, central to understanding how malignant tumors manipulate metabolic pathways to support their growth and survival. These alterations not only fuel rapid tumor expansion but also reshape the tumor microenvironment. This environment, in turn, impacts immune cell function, often creating an immunosuppressive habitat that allows cancer cells to evade the immune response. Additionally, the role of metabolic reprogramming in promoting cancer metastasis, the spread of cancer cells to new areas, complicates therapeutic approaches, making it a critical avenue for investigation.
This Research Topic aims to elucidate the complex interactions between cancer cell metabolism and immunotherapy effectiveness. By diving into the metabolic adaptations of cancer cells, this study seeks to uncover how these changes impair immune cell function and contribute to the cancer's ability to metastasize. Understanding these mechanisms could pave the way for novel therapeutic strategies that enhance immunotherapy responses and curb metastatic progression, ultimately aiming to improve survival rates in cancer patients.
To advance our understanding in this field, the scope of this research topic will focus on the metabolic underpinnings that facilitate cancer's evasion of immune surveillance and its ability to metastasize. We invite submissions that explore, but are not limited to, the following themes:
- The influence of cancer metabolism on the behavior and efficacy of immune cells.
- Metabolic checkpoints that could serve as new targets for immunotherapy.
- Metabolic reprogramming of immune cells like T cells and macrophages within the tumor microenvironment.
- Innovative combination therapies that integrate metabolic and immune-modulating approaches.
- Identification of biomarkers that connect metabolic and immune pathways to metastatic behavior, aiding in the development of personalized cancer treatments.
Keywords:
Cancer metabolism, Metabolic reprogramming, Tumor microenvironment, Immunotherapy, Metastasis
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Cancer metabolism is a critical area of research, central to understanding how malignant tumors manipulate metabolic pathways to support their growth and survival. These alterations not only fuel rapid tumor expansion but also reshape the tumor microenvironment. This environment, in turn, impacts immune cell function, often creating an immunosuppressive habitat that allows cancer cells to evade the immune response. Additionally, the role of metabolic reprogramming in promoting cancer metastasis, the spread of cancer cells to new areas, complicates therapeutic approaches, making it a critical avenue for investigation.
This Research Topic aims to elucidate the complex interactions between cancer cell metabolism and immunotherapy effectiveness. By diving into the metabolic adaptations of cancer cells, this study seeks to uncover how these changes impair immune cell function and contribute to the cancer's ability to metastasize. Understanding these mechanisms could pave the way for novel therapeutic strategies that enhance immunotherapy responses and curb metastatic progression, ultimately aiming to improve survival rates in cancer patients.
To advance our understanding in this field, the scope of this research topic will focus on the metabolic underpinnings that facilitate cancer's evasion of immune surveillance and its ability to metastasize. We invite submissions that explore, but are not limited to, the following themes:
- The influence of cancer metabolism on the behavior and efficacy of immune cells.
- Metabolic checkpoints that could serve as new targets for immunotherapy.
- Metabolic reprogramming of immune cells like T cells and macrophages within the tumor microenvironment.
- Innovative combination therapies that integrate metabolic and immune-modulating approaches.
- Identification of biomarkers that connect metabolic and immune pathways to metastatic behavior, aiding in the development of personalized cancer treatments.
Keywords:
Cancer metabolism, Metabolic reprogramming, Tumor microenvironment, Immunotherapy, Metastasis
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.